Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00030095
What this trial is testing

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02014454
What this trial is testing

Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature

Who this might be right for
Retinopathy of Prematurity
Meyer Children's Hospital IRCCS 23
Not applicableActive Not RecruitingNCT06597045
What this trial is testing

BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS

Who this might be right for
CancerCardiotoxicityAtherosclerotic Disease
NHS Greater Glasgow and Clyde 60
Large-scale testing (Phase 3)UnknownNCT03048877
What this trial is testing

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Peking Union Medical College Hospital 118
Early research (Phase 1)Study completedNCT01106872
What this trial is testing

Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas

Who this might be right for
SarcomaSoft Tissue SarcomaLocally Advanced Sarcoma+2 more
Mohammed M Milhem 47
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Large-scale testing (Phase 3)UnknownNCT00438867
What this trial is testing

Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization

Who this might be right for
Angina Pectoris
Cardium Therapeutics 300
Testing effectiveness (Phase 2)Ended earlyNCT02104011
What this trial is testing

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers

Who this might be right for
Renal AngiomyolipomasTuberous Sclerosis
University Hospital, Bordeaux 2
Testing effectiveness (Phase 2)Study completedNCT00090545
What this trial is testing

A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT01102946
What this trial is testing

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyRetinal Neovascularization
University of Sao Paulo 40
Not applicableEnded earlyNCT01746875
What this trial is testing

A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes

Who this might be right for
Macular DegenerationRetinal Detachment
Norwegian University of Science and Technology 9
Testing effectiveness (Phase 2)Ended earlyNCT00722865
What this trial is testing

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 25
Not applicableLooking for participantsNCT00842283
What this trial is testing

Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

Who this might be right for
Dermatologic Diseases
University of California, Irvine 85
Testing effectiveness (Phase 2)Study completedNCT00436956
What this trial is testing

AZD2171 to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 59
Not applicableStudy completedNCT02843230
What this trial is testing

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Who this might be right for
Glioblastoma
Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03271281
What this trial is testing

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

Who this might be right for
Neuroendocrine Tumors
Rigshospitalet, Denmark 113
Early research (Phase 1)Study completedNCT00129337
What this trial is testing

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Tumors
Peregrine Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT01283945
What this trial is testing

Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Institut de Recherches Internationales Servier 134
Large-scale testing (Phase 3)Ended earlyNCT00934739
What this trial is testing

High-Risk Oral Cavity Cancer

Who this might be right for
Oral Cavity Cancer
National Health Research Institutes, Taiwan 150
Early research (Phase 1)Study completedNCT00748891
What this trial is testing

DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)

Who this might be right for
Cancer
AstraZeneca 35
Next Page